Introduction: A key issue in NET management is the need for a specific and sensitive biomarker to detect disease and assess treatment. CgA is widely utilized but has limitations.
Aim(s): Validate a 51 transcript blood NET signature for the detection of NETs.
Materials and methods: PCR test in 2 independent NET sets (n=115; n=120) and in third prospective, blinded set of 150 NETs and 50 controls. Compare metrics to CgA (DAKO-ELISA).
Conference: 11th Annual ENETS Conference 2014 (2014)
Presenting Author: Professor Irvin M Modlin
To read results and conclusion, please login ...
Further abstracts you may be interested in